A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis
NCT00036439 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 364
Last updated 2011-05-17
Summary
The purpose of this study is to evaluate the effectiveness and safety of infliximab (Remicade) in patients with Ulcerative Colitis.
Conditions
Interventions
- DRUG
Sponsors & Collaborators
-
Centocor, Inc.
lead INDUSTRY
Principal Investigators
-
Centocor, Inc. Clinical Trial · Centocor, Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-02-28
- Completion
- 2007-01-31
More Related Trials
-
A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease
NCT00207662 ·Status: COMPLETED ·Phase: PHASE3
-
Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)
NCT03884439 ·Status: COMPLETED
-
A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence
NCT01190839 ·Status: TERMINATED ·Phase: PHASE3
-
A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis
NCT03398148 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis
NCT06269185 ·Status: COMPLETED
-
A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease
NCT00207675 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
NCT00487539 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)
NCT01346826 ·Status: COMPLETED ·Phase: PHASE4
-
"Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial"
NCT02452151 ·Status: UNKNOWN ·Phase: PHASE4
-
Open-Label Adalimumab for Ulcerative Colitis Patients
NCT00421642 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors
NCT02136069 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis
NCT00385736 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
NCT02163759 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of Reduced Infliximab Infusion Time
NCT05340764 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis
NCT00408629 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
NCT02407236 ·Status: COMPLETED ·Phase: PHASE3
-
Infliximab for the Prevention of Recurrent Crohn's Disease After Surgery
NCT00688636 ·Status: COMPLETED ·Phase: PHASE4
-
An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's Disease
NCT00269841 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis
NCT02065622 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Subcutaneous Infliximab in Acute Severe Ulcerative Colitis: a Multicenter Retrospective Study
NCT06998797 ·Status: NOT_YET_RECRUITING
-
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
NCT00694980 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study
NCT00279435 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
NCT01336465 ·Status: COMPLETED ·Phase: PHASE2
-
Basiliximab in Moderate to Severe Ulcerative Colitis
NCT00430898 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Blood Platelet Indices,Platelet Aggregation in the Activity of IBD Patients on Biological Treatment
NCT05406934 ·Status: UNKNOWN